Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — AXGN

Balance Sheet

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Cash & Equivalents	328.89	94.57	82.65	35.55	23.90	20.04	18.10	27.55	18.66	19.19	15.71	31.02	31.09	23.22	7.71	15.28	14.32	11.82	14.56	32.76
Short-term Investments	19.18	16.84	18.95	5.98	11.89	9.89	3.97	5.93	5.87	1.94	1.92	0.00	1.49	11.31	30.16	33.51	38.79	46.21	52.86	51.33
Accounts Receivable	34.01	34.13	28.31	26.17	30.78	28.03	26.30	24.11	24.63	25.15	24.21	25.15	23.26	21.57	22.28	22.19	21.36	20.37	18.59	18.16
Inventory	49.06	47.31	46.07	42.37	40.58	36.77	35.50	33.18	29.36	28.02	27.64	23.02	23.02	21.24	19.85	18.91	19.12	19.22	17.40	16.69
Total Current Assets	438.09	200.38	184.71	120.42	114.46	103.42	93.07	99.22	86.25	82.26	78.66	88.00	87.44	86.18	88.70	98.08	102.45	106.78	112.48	127.05
Property, Plant & Equipment	81.95	82.34	83.04	81.78	82.37	82.39	83.31	84.67	85.63	86.75	87.84	88.73	89.03	87.46	83.05	79.29	74.87	70.99	66.95	62.88
Intangible Assets	7.91	7.57	7.27	6.75	6.43	6.12	5.88	5.02	4.68	4.52	4.34	4.10	3.88	3.65	3.46	3.26	3.06	2.97	2.81	2.48
Total Non-current Assets*	112.25	104.49	104.78	101.27	101.94	102.03	103.10	104.51	105.73	106.67	107.85	108.82	107.19	105.47	100.78	97.31	93.07	89.31	85.55	80.97
Total Assets	550.34	304.86	289.49	221.69	216.40	205.45	196.17	203.73	191.99	188.93	186.52	196.83	194.63	191.64	189.47	195.39	195.52	196.08	198.03	208.02
Accounts Payable	34.63	28.40	23.90	21.18	25.67	22.77	19.66	28.64	21.18	21.66	21.29	28.88	25.55	22.89	20.19	22.44	22.02	21.84	20.87	22.46
Total Current Liabilities	36.46	30.37	26.01	23.56	28.01	24.98	21.75	30.61	23.03	23.42	22.93	30.43	26.65	23.93	21.24	23.75	23.55	23.60	22.95	24.29
Long-term Debt	0.00	0.00	0.00	48.39	48.16	47.94	47.72	47.50	47.27	47.05	46.83	46.60	46.38	46.15	45.93	45.71	45.49	45.26	45.04	44.82
Total Non-current Liabilities*	17.78	18.23	18.67	69.28	67.59	68.20	69.06	69.21	69.55	69.83	70.43	70.73	70.17	70.56	70.72	70.64	70.53	70.79	71.23	71.18
Total Liabilities	54.24	48.61	44.68	92.84	95.60	93.18	90.80	99.82	92.58	93.25	93.36	101.16	96.82	94.49	91.96	94.39	94.08	94.39	94.17	95.47
Retained Earnings	(325.73)	(328.06)	(326.55)	(306.96)	(293.81)	(294.51)	(295.09)	(291.26)	(291.71)	(289.85)	(287.93)	(281.30)	(277.40)	(273.31)	(266.65)	(259.58)	(254.16)	(249.85)	(242.11)	(230.63)
Total Stockholder Equity	496.10	256.26	244.81	128.85	120.81	112.28	105.37	103.91	99.41	95.69	93.16	95.67	97.81	97.15	97.51	101.00	101.45	101.69	103.85	112.55

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Total Revenue	75.83	69.73	61.46	59.90	60.08	56.66	48.56	49.40	48.64	47.91	41.38	42.92	41.27	38.16	36.66	36.16	36.96	34.45	31.01	31.54
Cost of Revenue	19.10	19.06	15.27	15.50	14.09	14.64	13.63	11.83	12.21	12.57	8.76	9.16	8.04	7.23	6.71	6.14	6.18	6.28	5.55	5.43
Gross Profit	56.73	50.67	46.19	44.41	45.99	42.02	34.93	37.57	36.44	35.35	32.62	33.76	33.23	30.93	29.96	30.02	30.78	28.17	25.46	26.11
Research & Development	8.95	8.59	7.52	12.38	7.57	6.85	6.09	6.70	7.00	6.66	7.41	7.30	6.99	7.36	6.68	6.81	7.05	7.02	6.28	6.30
Selling, General & Admin	16.47	13.41	12.87	14.59	10.84	9.69	9.46	8.83	10.83	9.42	9.96	7.48	8.84	9.63	9.00	8.94	8.80	9.40	9.62	7.43
Total Operating Expenses*	55.78	52.83	49.02	54.18	44.08	40.35	36.59	35.56	36.75	72.95	37.18	36.96	37.25	37.83	37.30	35.63	35.64	72.87	36.78	31.46
Operating Income	0.96	(2.16)	(2.83)	(9.77)	1.91	1.67	(1.66)	2.02	(0.32)	(0.43)	(4.56)	(3.19)	(4.03)	(6.90)	(7.34)	(5.61)	(4.86)	(7.92)	(11.32)	(5.35)
Interest Expense	--	--	--	--	--	--	--	--	--	--	2.33	1.84	0.83	0.15	0.02	(0.04)	0.06	0.25	0.35	(0.07)
Pretax Income*	2.33	(1.52)	(19.58)	(13.16)	0.71	0.58	(3.83)	0.45	--	--	--	--	--	--	--	--	--	--	--	--
Tax Provision	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	--	--	--	--	--	--	--	--	--	--	--	--
Net Income	2.33	(1.52)	(19.58)	(13.16)	0.71	0.58	(3.83)	0.45	(1.86)	(1.92)	(6.63)	(3.89)	(4.09)	(6.66)	(7.07)	(5.41)	(4.32)	(7.74)	(11.47)	(5.29)
Basic EPS	0.04	(0.03)	(0.38)	(0.29)	0.02	0.01	(0.08)	0.00	(0.04)	(0.04)	(0.15)	(0.08)	(0.10)	(0.16)	(0.17)	(0.14)	(0.10)	(0.18)	(0.27)	(0.12)
Diluted EPS	0.04	(0.03)	(0.38)	(0.28)	0.01	0.01	(0.08)	0.00	(0.04)	(0.04)	(0.15)	(0.08)	(0.10)	(0.16)	(0.17)	(0.14)	(0.10)	(0.18)	(0.27)	(0.12)

← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Operating Cash Flow	16.54	7.22	1.57	3.04	3.22	7.73	(13.18)	8.74	3.90	4.17	(12.27)	(0.21)	1.63	0.29	(7.42)	1.36	(0.69)	(5.69)	(11.05)	(1.51)
Capital Expenditures	1.39	0.89	2.79	1.25	1.52	0.72	0.26	0.67	0.60	0.91	0.92	1.46	3.69	4.42	4.30	6.62	4.37	4.05	5.04	7.17
Free Cash Flow*	15.14	6.33	(1.22)	1.79	1.70	7.01	(13.43)	8.07	3.30	3.26	(13.19)	(1.67)	(2.06)	(4.12)	(11.73)	(5.26)	(5.06)	(9.74)	(16.09)	(8.68)
Investing Cash Flow	(10.93)	0.50	(15.96)	4.04	(3.75)	(6.95)	1.34	(0.81)	(5.00)	(1.23)	(3.25)	(0.28)	5.99	14.32	(0.79)	(1.21)	2.97	2.28	(7.24)	(13.58)
Financing Cash Flow	228.71	4.20	59.51	4.57	2.39	1.16	2.38	0.97	0.57	0.54	0.20	0.42	0.01	0.90	0.63	0.81	0.22	0.67	0.10	1.04

← Scroll for more columns →

* Derived from reported values